Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease
Clinical trial NCT00142545 · COMPLETED
Trial details
- NCT number
- NCT00142545
- Sponsor
- Mylan Bertek Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-07-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.